Headquartered in Mountainside, New Jersey, Proteonomix Inc. is a biotechnology company trading on the Pink Sheets. Their corporate focus is on developing therapeutics based upon the use of human cells and their derivatives. The Company is developing proteins and cell therapies to treat a wide range of diseases. Proteonomix Inc. has facilities at several academic institutions.

Proteonomix is currently focusing on cosmetics, anti aging, and injury products. Their research and development program has produced over ten patent applications and they have multiple products ready to market. The Company’s subsidiary Proteoderm, Inc. commercializes the product line up. In the first quarter of this year, the Company’s new line of anti aging skin care products will hit the marketplace.

Proteonomix is developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. This platform may become the backbone of future stem cell research and the Company will make

Proteonomix Inc. is a biotechnology company dedicated to the development of cell therapies to treat a wide variety of diseases. Headquartered in Mountainside, New Jersey, their current research is focused on cosmetics, antiaging, and injury. Through their subsidiary ProteoDERM, INC., they are commercializing their various products.

Their new line of anti-aging skin care products is now hitting the market. Their ProteoDERM Inc.’s anti-aging products are their Matrix NC-138 system of products. They sell the Matrix NC-138™ (3%) Serum, and a Day Cream SPF-25, Night Cream, a Gentle Cleanser, and a Gentle Exfoliator.

Proteonomix is also developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. They will then make these available to the research community. They anticipate the commercialization of this product in the fourth quarter of this year. Proteonomix is working with leading scientists at prestigious institutions around the world to make tailored stem cell

Proteonomix Inc. is a biotechnology company dedicated to the development of cell therapies to treat a wide variety of diseases. Headquartered in Mountainside, New Jersey, their current research is focused on cosmetics, anti-aging, and injury. Through their subsidiary, ProteoDERM, INC., they are commercializing their various products.

Their new line of anti-aging skin care products is now hitting the market. These anti-aging products are the Matrix NC-138 system of products, sold as Matrix NC-138™ (3%) Serum, Day Cream SPF-25, Matrix Night Cream, a gentle cleanser and a gentle exfoliator.

Proteonomix is also developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. They will then make these available to the research community. They anticipate the commercialization of this product in the fourth quarter of this year. Proteonomix is working with leading scientists at prestigious institutions around the world to make tailored stem cell therapies a reality.

The